Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people - Wikidata - awgldk - TriplyDB

Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people

Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people

http://www.wikidata.org/entity/Q36334667

about

Stabilization of high-risk plaques Comorbidities and Metabolic Derangement of NAFLD Endocrine causes of nonalcoholic fatty liver disease Cholesterol-induced non-alcoholic fatty liver disease and atherosclerosis aggravated by systemic inflammation Cardiovascular disorders in the context of non-alcoholic Fatty liver disease: a literature review Association of insulin resistance and coronary artery remodeling: an intravascular ultrasound study.Cardiovascular risk assessment in patients with diabetes.Estrogen signaling prevents diet-induced hepatic insulin resistance in male mice with obesity.Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the Coronary Artery Risk Development in Young Adults Study.Independent Association between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: A Systematic Review and Meta-Analysis.Effects of kampo formulas on the progression of hypercholesterolemia and Fatty liver induced by high-cholesterol diet in rats.The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).Higher association of coronary artery calcification with non-alcoholic fatty liver disease than with abdominal obesity in middle-aged Korean men: the Kangbuk Samsung Health Study Association between nonalcoholic fatty liver disease and coronary artery calcification in postmenopausal women Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease.Nonalcoholic Fatty Liver Disease is Associated with Increased Carotid Intima-Media Thickness in Type 1 Diabetic Patients.Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease Arterial stiffness, fatty liver and the presence of coronary artery calcium in a large population cohort.Nonalcoholic Fatty liver: a possible new target for type 2 diabetes prevention and treatment.Assessment of the relationship between non-alcoholic fatty liver disease and diabetic complications.Nonalcoholic fatty liver disease is associated with low HDL cholesterol and coronary angioplasty in patients with type 2 diabetes.Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study.Omega-3 fatty acids: Mechanisms of benefit and therapeutic effects in pediatric and adult NAFLD.Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease.Nonalcoholic fatty liver disease is associated with coronary artery disease and subclinical atherosclerosis.Components of Boiogito Suppress the Progression of Hypercholesterolemia and Fatty Liver Induced by High-Cholesterol Diet in Rats.Fatty Liver, Insulin Resistance, and Obesity: Relationships With Increase in Coronary Artery Calcium Over Time.Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study.Fatty liver index is a risk determinant of incident type 2 diabetes in a metabolically healthy population with obesity.How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound.Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study.Digenic mutations on SCAP and AGXT2 predispose to premature myocardial infarction.The Correlation Between Obesity-Related Diseases and Non-alcoholic Fatty Liver Disease in Women in the Pre-operative Evaluation for Bariatric Surgery Assessed by Transient Hepatic Elastography.Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: A cross-sectional, population-based study in middle-aged subjects Localization of fat depots and cardiovascular risk Association between serum uric acid and arterial stiffness in a low-risk, middle-aged, large Korean population: A cross-sectional study

P2860

Q26738584-C116F683-D3C8-4A72-8DCF-BB1B2EBD13FD Q26777147-A32A7234-C83D-4550-A760-59B1D2BFABC5 Q26780254-AA10BE1E-4837-44D2-A317-283552DFB8FC Q27331466-421235DA-F8FF-488B-BDB2-D39EAE7B3D58 Q28081066-072E5555-EB04-4A81-B6FE-78B545E45E54 Q30408893-BC6B0FBB-A1CD-46DD-B682-533B5B9C944A Q33582582-2D42164F-F10B-4C29-A321-BAEC9D2A7FA3 Q33976390-1DE69F0D-449B-4DC2-B580-EFD5CA666DD5 Q34011629-4E43FA42-94D9-4749-91BE-6FFF97FD97B7 Q34729697-C23266D6-3672-4ED0-8D3B-0E723B3489AF Q35502801-9809C11A-4F9C-42C2-9322-58317E9D645E Q35525608-E824EFEB-E27E-4B58-897B-4E5F17A1FE36 Q35848217-9001BD57-F0B2-4E74-9EAF-5A436B16D633 Q36336631-E4437D50-1D4B-43E5-AA03-04D87C511C0E Q36658454-27F1070A-20F0-46B0-8DD8-1B107513D353 Q36937278-F84E1AD3-943F-49E3-9487-27E332811CCB Q37002532-2A5AE8C2-58C5-47E6-9361-5E17324D99F6 Q37305779-AF514C48-A7C5-44EA-A925-ACDD14B90F92 Q37375539-5DB9D28A-59B7-4F8F-BA32-13EDB5CAFB4F Q37385527-9A50864B-CEA2-4F4C-B7FE-A97B4BD105AE Q37411158-FF851CE8-0C64-46DF-8E80-84DF5F60DE97 Q37596189-3383D453-7EE6-45D1-B7B2-CE1D0F0150DF Q37615518-2E38A663-33CA-484A-81A4-2866F0F487FF Q38606360-C95508F1-3677-4671-9249-0850FAB0BC92 Q38711424-E4C4A34C-7630-4E28-A370-1AEEB206062E Q38854485-6EA02330-819F-45A5-8F0C-6E9C17247FC2 Q39759671-728B52A8-4C96-4BBC-86A6-FC8C7CA1E07E Q39903509-EE3FBD37-B2A1-4187-ABCD-2C27A0E21C0E Q40593113-C9E725F1-273A-4095-85B8-04A60BC33B5C Q40782855-E13EA748-10DE-40B5-B1D6-B692EE598104 Q44751613-BF6500C4-8016-4E7A-8C47-0F6A1A694459 Q46220517-14C1E893-14E3-4F86-AEFA-039D416E4DEF Q47104597-CB5C692E-3C2B-4920-A8B0-9810AC76EC16 Q50938841-DB671F56-7C9F-431C-B13B-6950F24B821E Q58588579-48C9EA91-6BCA-440B-8DB0-FCF3D5645C9C Q58722876-B0EF185B-70A7-4BDF-B044-AFC10BD87D57 Q58737832-ECCE63D7-7454-4460-86D8-A04D4553CC7E Q58759139-B1F6647D-8598-4EB6-ACF6-3812CCDA475A

P2860

Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people

http://www.wikidata.org/entity/Q36334667

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Fatty liver, insulin resistanc ...... rtery calcium in 10,153 people

@ast

Fatty liver, insulin resistanc ...... rtery calcium in 10,153 people

@en

type

label

Fatty liver, insulin resistanc ...... rtery calcium in 10,153 people

@ast

Fatty liver, insulin resistanc ...... rtery calcium in 10,153 people

@en

prefLabel

Fatty liver, insulin resistanc ...... rtery calcium in 10,153 people

@ast

Fatty liver, insulin resistanc ...... rtery calcium in 10,153 people

@en

P1433

Q36334667-1243E7EB-BE90-4B31-A967-4F6687CABFA5

P1476

Q36334667-0F7FFCB3-D7D7-4161-872C-BC8FFC67BAE9

P2093

Q36334667-156C8656-884E-4226-8CE7-3533720B56B0

Q36334667-78C0BD53-52B9-4CAC-B546-260F80C3ABB2

Q36334667-E909464F-0F5B-47AA-8A13-1E67CDC3D12B

Q36334667-F328C20F-3AA0-4B2D-B03C-865DCC694F42

P2860

Q36334667-037590ED-A9F4-4FEB-A0CE-FAD6EE748B58

Q36334667-062B1AB3-3D42-44C3-A4DC-DCB2A825AC23

Q36334667-062F07A6-C59C-4D1C-B315-8B91A1E3D271

Q36334667-1FC0D469-D5FF-48CD-B657-80431FBE62CC

Q36334667-21F2DE42-A017-42D0-BA20-3F7B513DEF04

Q36334667-242C268E-5D72-433C-AD8F-DA78EB774503

Q36334667-2AB736D6-1018-40E0-952C-F2B22A1257B2

Q36334667-2F30DB33-18B7-467B-9E64-BD5E2F3B43F8

Q36334667-436EF8C1-3D68-49EA-A51E-1808387B927E

Q36334667-48567E9A-3D2F-4F0F-AE7D-899C3EE04276

P304

Q36334667-E65104D4-8399-4688-B001-43DFFAD199C2

P31

Q36334667-3A65B705-C0D4-4673-89FC-99A5E6585B27

P356

Q36334667-FF7A1A77-8FB4-4EF6-9A2F-724DA22F0A65

P407

Q36334667-B3FBAF80-F8D7-4444-95C0-EDD53A34A683

P433

Q36334667-4588484D-45F4-42EE-97C2-3F1F9467FF39

P478

Q36334667-D4A70FFE-74BA-4883-9CB5-DFA41F708A22

P577

Q36334667-D5605640-9F85-4D7B-AA97-EC90EB498BA6

P5875

Q36334667-23164324-4489-420C-AAE1-99EB847E83C7

P698

Q36334667-14DAFF0A-67A0-491E-9C49-A5C13FEBC57D

P921

Q36334667-C4D24DD3-CB19-43FF-9523-0442BF73183D

P932

Q36334667-3C8A68B7-2DE0-423B-B689-0A696A6E4A6B

P356

P1433

P1476

Fatty liver, insulin resistanc ...... rtery calcium in 10,153 people

@en

P2093

Christopher D Byrne

http://www.w3.org/2001/XMLSchema#string

Hyon Joo Kwag

http://www.w3.org/2001/XMLSchema#string

Ki-Chul Sung

http://www.w3.org/2001/XMLSchema#string

Sarah H Wild

http://www.w3.org/2001/XMLSchema#string

P2860

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

Long-term follow-up of patients with NAFLD and elevated liver enzymes

Ultrasound scanning in the detection of hepatic fibrosis and steatosis

Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study.

Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults.

Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committe

The relationship between insulin resistance and incidence and progression of coronary artery calcification: the Multi-Ethnic Study of Atherosclerosis (MESA).

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

P304

2359-2364

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC12-0515

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230565784

http://www.w3.org/2001/XMLSchema#string

P698

22829522

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

P932

3476919

http://www.w3.org/2001/XMLSchema#string